SCINAI IMMUNOTHERAPEUTICS LTD. Cash Flows From Used In Investing Activities
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Cash Flows From Used In Investing Activities of -ILS 84.00 thousand for the 3-month period ending 2022-06-30, per its 6-K/A filed 2022-08-29.
Discontinued › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2022-08-29
- SCINAI IMMUNOTHERAPEUTICS LTD. cash flows from used in investing activities for the quarter ending 2022-06-30 was -84.00K ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. cash flows from used in investing activities for the quarter ending 2021-12-31 was -256.00K ILS, a 179.75% decline year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. cash flows from used in investing activities for the quarter ending 2021-09-30 was -13.00K ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. cash flows from used in investing activities for the quarter ending 2021-06-30 was -107.00K ILS.
ILS
| Period end | Cash Flows From Used In Investing Activities 3 month | Cash Flows From Used In Investing Activities 6 month | Cash Flows From Used In Investing Activities 9 month | Cash Flows From Used In Investing Activities 12 month |
|---|---|---|---|---|
| 2022-06-30 | -84.00K ILS 6-K/A · filed 2022-08-29 | -1.74M ILS 6-K/A · filed 2022-08-29 | ||
| 2021-12-31 | -256.00K ILS derived: 6-K/A 12 month − 6-K/A 9 month · filed 2022-08-29 | -269.00K ILS derived: sum of 2 quarters · filed 2022-08-29 | -376.00K ILS derived: sum of 3 quarters · filed 2022-08-29 | -361.00K ILS 6-K/A · filed 2022-08-29 |
| 2021-09-30 | -13.00K ILS 6-K/A · filed 2021-12-27 | -120.00K ILS derived: sum of 2 quarters · filed 2022-08-29 | -105.00K ILS 6-K/A · filed 2021-12-27 | |
| 2021-06-30 | -107.00K ILS 6-K/A · filed 2022-08-29 | -92.00K ILS 6-K/A · filed 2022-08-29 | ||
| 2020-12-31 | 321.00K ILS derived: 20-F 12 month − 6-K/A 9 month · filed 2022-03-28 | -3.03M ILS derived: sum of 2 quarters · filed 2022-03-28 | -4.33M ILS derived: sum of 3 quarters · filed 2022-03-28 | -5.93M ILS 20-F · filed 2022-03-28 |
| 2020-09-30 | -3.35M ILS 6-K/A · filed 2021-12-27 | -4.66M ILS derived: sum of 2 quarters · filed 2021-12-27 | -6.26M ILS 6-K/A · filed 2021-12-27 | |
| 2020-06-30 | -1.31M ILS 6-K · filed 2020-10-02 | -2.91M ILS 6-K · filed 2020-10-02 | ||
| 2019-12-31 | -991.00K ILS derived: 20-F 12 month − 6-K 9 month · filed 2022-03-28 | -3.15M ILS derived: sum of 2 quarters · filed 2022-03-28 | -4.04M ILS derived: sum of 3 quarters · filed 2022-03-28 | -7.20M ILS 20-F · filed 2022-03-28 |
| 2019-09-30 | -2.16M ILS 6-K · filed 2021-01-28 | -3.04M ILS derived: sum of 2 quarters · filed 2021-01-28 | -6.21M ILS 6-K · filed 2021-01-28 | |
| 2019-06-30 | -883.00K ILS 6-K · filed 2020-10-02 | -4.05M ILS 6-K · filed 2020-10-02 | ||
| 2018-12-31 | -23.45M ILS 20-F · filed 2021-05-13 | |||
| 2017-12-31 | 6.76M ILS 20-F · filed 2020-06-12 | |||
| 2016-12-31 | -7.81M ILS 20-F · filed 2019-04-30 | |||
| 2015-12-31 | -43.00K ILS 20-F · filed 2018-04-30 |
USD
| Period end | Cash Flows From Used In Investing Activities 3 month | Cash Flows From Used In Investing Activities 6 month | Cash Flows From Used In Investing Activities 9 month | Cash Flows From Used In Investing Activities 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$497.00K 6-K/A · filed 2022-08-29 | |||
| 2021-12-31 | -$83.00K derived: 20-F 12 month − 6-K/A 9 month · filed 2022-03-28 | -$116.00K 20-F · filed 2022-03-28 | ||
| 2021-09-30 | -$33.00K 6-K/A · filed 2021-12-27 | |||
| 2020-12-31 | -$1.84M 20-F · filed 2021-05-13 | |||
| 2017-12-31 | $1.95M 20-F · filed 2018-04-30 |